Egbert Smit

25PUBLICATIONS
208CO-AUTHORS
Molecular targetsContext learningCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 10, 2026
Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.

|Jul 29, 2026
Validation of a Text-Mining Tool for Extracting Routine Clinical Care Data in Early-Stage Resectable Non-Small Cell Lung Cancer.

|Nov 28, 2025
Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

Daphne van der Geest, Alex van Vliet, Daniel S Peeper

|Oct 19, 2025
Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.

Melissa L Johnson, Egbert F Smit, Enriqueta Felip

|Sep 01, 2025
Interstitial lung disease epidemiology and etiology in patients with solid malignant tumors: a systematic literature review.

Egbert F Smit, Simon M Collin, Manoj Prahladan

|Jun 24, 2025
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy.

Conor E Steuer, Hidetoshi Hayashi, Wu-Chou Su

Pageof 5

Frequent Collaborators

6 joint publications

Enriqueta Felip

5 joint publications

Kim Monkhorst

5 joint publications

Michel M van den Heuvel

4 joint publications

Melissa L Johnson